8 points | by maxall4 15 hours ago
1 comments
1. takes unlicensed peptides, because the insurance declined to pay for what the doctor prescribed.
2. «“people generally don't try to quantify tail risks.” Among the people I talked to, this is true»
That’s a pretty bad outlook.
1. takes unlicensed peptides, because the insurance declined to pay for what the doctor prescribed.
2. «“people generally don't try to quantify tail risks.” Among the people I talked to, this is true»
That’s a pretty bad outlook.